MD ANDERSON CANCER CENTER named eight young researchers Andrew Sabin Family Fellows at an event honoring their benefactor, Andrew Sabin, and representatives of the Andrew Sabin Family Foundation. Eight cancer research fellowships providing $100,000 over two years are to be awarded annually in four categories: basic science, clinical, physician-scientist and population and quantitative science. The […]
AVINASH DESAI was named vice president of Americas Oncology Medical Affairs for the Oncology Business Group of Eisai Inc., the U.S. pharmaceutical subsidiary of Eisai Co. Ltd. Desai will lead Eisai’s Oncology Medical Affairs team by creating and overseeing the medical strategy for the Oncology Commercial and Market Access businesses in the Americas. Desai, who […]
AL BENSON III was elected president of the National Patient Advocate Foundation’s executive board. Benson is associate director for cooperative groups at the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. He has served on the foundation’s board for three years and also served on the scientific advisory committee since 2009. “I am honored […]
JOHN WESTON was named chief operating officer and executive vice president of the Prostate Cancer Foundation. Most recently Weston served as public affairs department chair and chief marketing officer for the Mayo Clinic. He began his career at Mars Inc., held senior leadership positions at FedEx and was the chief marketing and corporate development officer […]
MARGARET FOTI was honored at the 41st Annual Congress of the Oncology Nursing Society with the Honorary Member Award. Foti is chief executive officer of the American Association for Cancer Research. The Honorary Member Award is awarded by the ONS to thank and honor an individual who is not otherwise eligible for ONS membership for […]
JENNIFER PIETENPOL was named executive vice president for research at Vanderbilt University Medical Center, effective May 1.
The Patient-Centered Outcomes Research Institute approved $44.4 million in funding for 21 new patient-centered comparative clinical effectiveness research studies.
Over 150 organizations sent an open letter to the leaders of the Senate Health, Labor, Educations and Pensions Committee, supporting them for advancing legislation that will form the basis of the Senate's version of the 21st Century Cures Act, which passed the House last year.
“And I believe we need a moonshot in this country to cure cancer.”
The Genomic Data Commons, NCI's latest big data project, is poised to become a major player in oncology bioinformatics when it opens June 1.